Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Cash & Equivalents: 2020-2024

Historic Cash & Equivalents for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $20.3 million.

  • Journey Medical's Cash & Equivalents rose 10.88% to $24.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year increase of 10.88%. This contributed to the annual value of $20.3 million for FY2024, which is 26.00% down from last year.
  • Latest data reveals that Journey Medical reported Cash & Equivalents of $20.3 million as of FY2024, which was down 26.00% from $27.4 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Cash & Equivalents ranged from a high of $49.1 million in FY2021 and a low of $8.2 million during FY2020.
  • Over the past 3 years, Journey Medical's median Cash & Equivalents value was $27.4 million (recorded in 2023), while the average stood at $26.6 million.
  • As far as peak fluctuations go, Journey Medical's Cash & Equivalents surged by 495.44% in 2021, and later slumped by 34.82% in 2022.
  • Over the past 5 years, Journey Medical's Cash & Equivalents (Yearly) stood at $8.2 million in 2020, then soared by 495.44% to $49.1 million in 2021, then slumped by 34.82% to $32.0 million in 2022, then declined by 14.26% to $27.4 million in 2023, then declined by 26.00% to $20.3 million in 2024.